BEQALZI

Serial Number 99162966
686

Registration Progress

Application Filed
Apr 30, 2025
Under Examination
Approved for Publication
Jul 1, 2025
Published for Opposition
Jul 1, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Jul 31, 2025 22 days

Basic Information

Serial Number
99162966
Filing Date
April 30, 2025
Published for Opposition
July 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 1, 2025
Application
Pending
Classes
005

Rights Holder

BeiGene Switzerland GmbH

99
Address
Aeschengraben 27
Basel 4051
CH

Ownership History

BeiGene Switzerland GmbH

Original Applicant
99
Basel CH

BeiGene Switzerland GmbH

Owner at Publication
99
Basel CH

Legal Representation

Attorney
Kristen S. Ruisi

USPTO Deadlines

Next Deadline
22 days remaining
Notice of Publication
Due Date
July 31, 2025
Extension Available
Until August 31, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description
Jul 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 25, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2025 CHPB I POST PUBLICATION AMENDMENT - ENTERED
Jun 12, 2025 ALIE A ASSIGNED TO LIE
Jun 4, 2025 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
May 31, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2025 DOCK D ASSIGNED TO EXAMINER
Apr 30, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Apr 30, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification

International Classes
005